Fibroblast Growth Factor 21 Protects Against Cerebral Ischemia/Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis
FGF21 protects CIRI by inhibiting OxS and ferroptosis. The CYBB, a new key regulator, may mediate its anti-ferroptotic effects, offering new insights into CIRI therapies.
Authors
- Wenya Bai (ORCID: https://orcid.org/0000-0001-5329-2527)
- Haiyan Jiang (ORCID: https://orcid.org/0000-0002-5778-4008)
- Junjie Li (ORCID: https://orcid.org/0000-0001-7664-8856)
- Wendong Chen (ORCID: https://orcid.org/0000-0002-9388-7653)
- Yuan Yang (ORCID: https://orcid.org/0000-0002-1259-5334)
- Jianlin Shao (ORCID: https://orcid.org/0000-0001-9878-7064)
- Guilin Zhou (ORCID: https://orcid.org/0000-0003-4909-2834)
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Neuropsychiatric Disease and Treatment
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ndt.s504180
- Citations
- 1
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81